Vascular endothelial growth factor (VEGF) and its receptor (VEGFR) play a crucial role in physiological and pathological angiogenesis. Since the growth of malignant tumors cannot be separated from the support of neovascularization, anti-tumor angiogenesis drugs that inhibit VEGF/VEGFR system have become one of the important means of tumor drug therapy. With the wide application of drugs in clinical practice, nephrotoxicity manifested as proteinuria occurs in some patients during the course of medication, and its pathogenesis is still unclear. This article reviews the incidence, mechanism, clinical diagnosis and treatment of proteinuria induced by the clinical use of anti-tumor angiogenesis drugs, in order to provide reference for clinical medication.
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |